Search NASA⌕ Search

Engineering topics

Zhang, Leili

Publications and source records attributed to Zhang, Leili.

Scalable multiscale modeling of platelets with 100 million particles

Here, we developed the core components of the AI-aided multiple time stepping algorithm for multiscale modeling of cell dynamics. This algorithm was implemented and analyzed on two supercomputer architectures with an application of simulating the aggregation of 250 platelets, or 102 million particles. To scale on these computers with complex memory and network architectures with GPUs, we devised a biomechanics-informed task mapping scheme to optimize load imbalance, communications, and memory utilization. Our simulations, scaling well up to 192 nodes on a Summit-like supercomputer with a peak speed of 11 petaflops, achieved a rate of 423 μs/day which is 500 times faster than the conventional algorithm using static time step and this has enabled studies of record size blood clots at record spatial–temporal resolutions. Additionally, we discovered the sensitive dependence of the scalability and execution time on the methods of decomposition, CPU–GPU coupling, and task mapping.

97 MATHEMATICS AND COMPUTING↗

Dynamics-Based Peptide–MHC Binding Optimization by a Convolutional Variational Autoencoder: A Use-Case Model for CASTELO

An unsolved challenge in the development of antigen-specific immunotherapies is determining the optimal antigens to target. Comprehension of antigen–major histocompatibility complex (MHC) binding is paramount toward achieving this goal. Here, we apply CASTELO, a combined machine learning-molecular dynamics (ML-MD) approach, to identify per-residue antigen binding contributions and then design novel antigens of increased MHC-II binding affinity for a type 1 diabetes-implicated system. We build upon a small-molecule lead optimization algorithm by training a convolutional variational autoencoder (CVAE) on MD trajectories of 48 different systems across four antigens and four HLA serotypes. We develop several new machine learning metrics including a structure-based anchor residue classification model as well as cluster comparison scores. ML-MD predictions agree well with experimental binding results and free energy perturbation-predicted binding affinities. Moreover, ML-MD metrics are independent of traditional MD stability metrics such as contact area and root-mean-square fluctuations (RMSF), which do not reflect binding affinity data. Finally, our work supports the role of structure-based deep learning techniques in antigen-specific immunotherapy design.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

CASTELO: clustered atom subtypes aided lead optimization—a combined machine learning and molecular modeling method

Background: Drug discovery is a multi-stage process that comprises two costly major steps: pre-clinical research and clinical trials. Among its stages, lead optimization easily consumes more than half of the pre-clinical budget. We propose a combined machine learning and molecular modeling approach that partially automates lead optimization workflow in silico, providing suggestions for modification hot spots. Results: The initial data collection is achieved with physics-based molecular dynamics simulation. Contact matrices are calculated as the preliminary features extracted from the simulations. To take advantage of the temporal information from the simulations, we enhanced contact matrices data with temporal dynamism representation, which are then modeled with unsupervised convolutional variational autoencoder (CVAE). Finally, conventional and CVAE-based clustering methods are compared with metrics to rank the submolecular structures and propose potential candidates for lead optimization. Conclusion: With no need for extensive structure-activity data, our method provides new hints for drug modification hotspots which can be used to improve drug potency and reduce the lead optimization time. It can potentially become a valuable tool for medicinal chemists.

59 BASIC BIOLOGICAL SCIENCES↗